Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110876743 | 11087674 | 3 | F | 201504 | 20160707 | 20150504 | 20160714 | EXP | US-PFIZER INC-2015149169 | PFIZER | 77.00 | YR | F | Y | 60.00000 | KG | 20160714 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110876743 | 11087674 | 1 | PS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, DAILY | 20753 | 25 | MG | COATED TABLET | |||||||
| 110876743 | 11087674 | 2 | SS | AROMASIN | EXEMESTANE | 1 | Oral | 25 MG, 1X/DAY | Z995L | 20753 | 25 | MG | COATED TABLET | QD | |||||
| 110876743 | 11087674 | 3 | C | BENICAR | OLMESARTAN MEDOXOMIL | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
| 110876743 | 11087674 | 4 | C | PRAVASTATIN. | PRAVASTATIN | 1 | Oral | 40 MG, 1X/DAY | 0 | 40 | MG | TABLET | QD | ||||||
| 110876743 | 11087674 | 5 | C | CLARITIN | LORATADINE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 110876743 | 11087674 | 6 | C | GLIPIZIDE. | GLIPIZIDE | 1 | 5 MG, 2X/DAY | 0 | 5 | MG | TABLET | BID | |||||||
| 110876743 | 11087674 | 7 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 5 MG, 1X/DAY | 0 | 5 | MG | TABLET | QD | ||||||
| 110876743 | 11087674 | 8 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 81 MG, 1X/DAY | 0 | 81 | MG | QD | |||||||
| 110876743 | 11087674 | 9 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | Oral | 1000 MG, 1X/DAY | 0 | 1000 | MG | TABLET | QD | ||||||
| 110876743 | 11087674 | 10 | C | LOSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | UNK, ((LOSARTAN POTASSIUM:100 MG; HYDROCHLOROTHIAZIDE:12.5 MG), 1X/DAY | 0 | TABLET | QD | ||||||||
| 110876743 | 11087674 | 11 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | UNK, (ONE TABLET), DAILY | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110876743 | 11087674 | 1 | Breast cancer |
| 110876743 | 11087674 | 3 | Blood pressure abnormal |
| 110876743 | 11087674 | 4 | Blood cholesterol abnormal |
| 110876743 | 11087674 | 6 | Diabetes mellitus |
| 110876743 | 11087674 | 9 | Fatigue |
| 110876743 | 11087674 | 10 | Blood pressure abnormal |
| 110876743 | 11087674 | 11 | Bone deformity |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110876743 | 11087674 | HO |
| 110876743 | 11087674 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110876743 | 11087674 | Breast pain | |
| 110876743 | 11087674 | Condition aggravated | |
| 110876743 | 11087674 | Cough | |
| 110876743 | 11087674 | Dysphonia | |
| 110876743 | 11087674 | Fatigue | |
| 110876743 | 11087674 | Hypoacusis | |
| 110876743 | 11087674 | Pain | |
| 110876743 | 11087674 | Pneumonia | |
| 110876743 | 11087674 | Sinus disorder | |
| 110876743 | 11087674 | Throat irritation | |
| 110876743 | 11087674 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 110876743 | 11087674 | 1 | 2010 | 0 | ||
| 110876743 | 11087674 | 3 | 201601 | 0 | ||
| 110876743 | 11087674 | 7 | 2002 | 0 | ||
| 110876743 | 11087674 | 9 | 2016 | 0 | ||
| 110876743 | 11087674 | 10 | 201601 | 0 | ||
| 110876743 | 11087674 | 11 | 201605 | 0 |